Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial-Reference-Cited by-同舟云学术

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

Published:2003-03 Issue:1 Volume:4 Page:45-52
ISSN:1527-0297
Container-title:High Altitude Medicine & Biology
language:en
Short-container-title:High Altitude Medicine & Biology

Author:

Basnyat Buddha¹,Gertsch Jeffrey H.²,Johnson E. William²,Castro-Marin Franco²,Inoue Yoshio²,Yeh Clement²

Affiliation:

1. Medical Director, Nepal International Clinic, Himalayan Rescue Association (HRA); Professor of Physiology, Institute of Medicine; Consultant in Medicine, Patan Hospital; Faculty, Good Samaritan Medical Center, Phoenix, AZ

2. American upper-level medical student researching in the Himalayas for the HRA

Publisher

Mary Ann Liebert Inc

Subject

Public Health, Environmental and Occupational Health,Physiology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/152702903321488979

Reference13 articles.

1. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review

2. Acetazolamide in the Treatment of Acute Mountain Sickness: Clinical Efficacy and Effect on Gas Exchange

3. Pharmacological prevention of acute mountain sickness

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altitude illnesses;Nature Reviews Disease Primers;2024-06-20

2. Using modified Fenn diagrams to assess ventilatory acclimatization during ascent to high altitude: Effect of acetazolamide;Experimental Physiology;2024-05-15

3. Ibuprofen Compared to Acetazolamide for the Prevention of Acute Mountain Sickness: A Randomized Placebo-Controlled Trial;Cureus;2024-03-12

4. Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?;Journal of Travel Medicine;2023-01-25

5. Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial;Pulmonology;2023-01